Tag: GLP-1

Eli Lilly
Healthcare
USA

Valuation Analysis: Eli Lilly and Company

Eli Lilly reported an exceptionally strong Q2 2026. Growth and higher guidance impress, but valuation, pricing pressure, and cash flow
Active icon
Continue Umbrella
Eli Lilly
Healthcare
USA

Stock: Eli Lilly and Company

Eli Lilly is one of the leading pharmaceutical companies worldwide. Growth drivers include Mounjaro, Zepbound, and a strong pipeline in
Active icon
Continue Umbrella